148 related articles for article (PubMed ID: 11687007)
1. Photodynamic therapy for neovascular age-related macular degeneration.
Wormald R; Evans J; Smeeth L; Henshaw K
Cochrane Database Syst Rev; 2001; (3):CD002030. PubMed ID: 11687007
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy for neovascular age-related macular degeneration.
Wormald R; Evans J; Smeeth L
Cochrane Database Syst Rev; 2000; (2):CD002030. PubMed ID: 10796845
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy for neovascular age-related macular degeneration.
Wormald R; Evans J; Smeeth L; Henshaw K
Cochrane Database Syst Rev; 2003; (2):CD002030. PubMed ID: 12804420
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy for neovascular age-related macular degeneration.
Wormald R; Evans J; Smeeth L; Henshaw K
Cochrane Database Syst Rev; 2005 Oct; (4):CD002030. PubMed ID: 16235294
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy for neovascular age-related macular degeneration.
Wormald R; Evans J; Smeeth L; Henshaw K
Cochrane Database Syst Rev; 2007 Jul; (3):CD002030. PubMed ID: 17636693
[TBL] [Abstract][Full Text] [Related]
6. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
7. Macular translocation for neovascular age-related macular degeneration.
Eandi CM; Giansanti F; Virgili G
Cochrane Database Syst Rev; 2008 Oct; (4):CD006928. PubMed ID: 18843739
[TBL] [Abstract][Full Text] [Related]
8. Verteporfin photodynamic therapy for neovascular age-related macular degeneration: cohort study for the UK.
Reeves BC; Harding SP; Langham J; Grieve R; Tomlin K; Walker J; Guerriero C; Carpenter J; Patton WP; Muldrew KA; Peto T; Chakravarthy U
Health Technol Assess; 2012; 16(6):i-xii, 1-200. PubMed ID: 22348600
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
10. Surgical implantation of steroids with antiangiogenic characteristics for treating neovascular age-related macular degeneration.
Geltzer A; Turalba A; Vedula SS
Cochrane Database Syst Rev; 2007 Oct; (4):CD005022. PubMed ID: 17943833
[TBL] [Abstract][Full Text] [Related]
11. Occult with no classic subfoveal choroidal neovascular lesions in age-related macular degeneration: clinically relevant natural history information in larger lesions with good vision from the Verteporfin in Photodynamic Therapy (VIP) Trial: VIP Report No. 4.
Pieramici DJ; Bressler SB; Koester JM; Bressler NM
Arch Ophthalmol; 2006 May; 124(5):660-4. PubMed ID: 16682587
[TBL] [Abstract][Full Text] [Related]
12. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
Azab M; Benchaboune M; Blinder KJ; Bressler NM; Bressler SB; Gragoudas ES; Fish GE; Hao Y; Haynes L; Lim JI; Menchini U; Miller JW; Mones J; Potter MJ; Reaves A; Rosenfeld PJ; Strong A; Su XY; Slakter JS; Schmidt-Erfurth U; Sorenson JA; ;
Retina; 2004 Feb; 24(1):1-12. PubMed ID: 15076937
[TBL] [Abstract][Full Text] [Related]
13. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
Bressler NM; Arnold J; Benchaboune M; Blumenkranz MS; Fish GE; Gragoudas ES; Lewis H; Schmidt-Erfurth U; Slakter JS; Bressler SB; Manos K; Hao Y; Hayes L; Koester J; Reaves A; Strong HA;
Arch Ophthalmol; 2002 Nov; 120(11):1443-54. PubMed ID: 12427056
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant vitamin and mineral supplements for age-related macular degeneration.
Evans JR
Cochrane Database Syst Rev; 2002; (2):CD000254. PubMed ID: 12076389
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy for occult choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration.
Axer-Siegel R; Ehrlich R; Rosenblatt I; Kramer M; Priel E; Yassur Y; Weinberger D
Arch Ophthalmol; 2004 Apr; 122(4):453-9. PubMed ID: 15078661
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant vitamin and mineral supplements for age-related macular degeneration.
Evans JR
Cochrane Database Syst Rev; 2002; (1):CD000254. PubMed ID: 11869572
[TBL] [Abstract][Full Text] [Related]
17. Guidelines for using verteporfin (Visudyne) in photodynamic therapy for choroidal neovascularization due to age-related macular degeneration and other causes: update.
Verteporfin Roundtable Participants
Retina; 2005; 25(2):119-34. PubMed ID: 15689800
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for neovascular age-related macular degeneration.
Sivagnanavel V; Evans JR; Ockrim Z; Chong V
Cochrane Database Syst Rev; 2004 Oct; (4):CD004004. PubMed ID: 15495075
[TBL] [Abstract][Full Text] [Related]
19. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
Miller JW; Schmidt-Erfurth U; Sickenberg M; Pournaras CJ; Laqua H; Barbazetto I; Zografos L; Piguet B; Donati G; Lane AM; Birngruber R; van den Berg H; Strong A; Manjuris U; Gray T; Fsadni M; Bressler NM; Gragoudas ES
Arch Ophthalmol; 1999 Sep; 117(9):1161-73. PubMed ID: 10496388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
